In this program, experts will discuss the risk factors for, and risks of hyperkalemia, treatment goals of acute and chronic hyperkalemia, the importance of RAASi in CKD and HF patients, the potential adverse outcomes in individuals with ESRD undergoing adequate hemodialysis with predialysis hyperkalemia, and evidence with K+ binders in various patient populations.